Navigation Links
IDEV Technologies Names Christopher M. Owens President, Chief Executive Officer
Date:11/17/2009

HOUSTON, Nov. 17 /PRNewswire/ -- IDEV Technologies, Incorporated (IDEV), an emerging leader in the development and marketing of minimally invasive medical technologies, today announced it has named Christopher M. Owens its President and Chief Executive Officer, effective immediately.

"Chris has a proven track record of results-based leadership and is the right person to take the Company to the next level," said Board Chairman Rick Anderson. "Chris has a clear vision and strategy of how we will advance IDEV through an explosive growth phase. We are confident and proud to have Chris leading the organization."

Mr. Owens has nearly 20 years of medical device experience holding senior-level executive positions in both the commercial and technical areas. Prior to coming to IDEV, he was Vice President of Worldwide Marketing for MicroVention from 2005-2008, a start-up medical device company that was purchased by Terumo Corporation. From 2003-2005, he was Vice President, Global Research and Development for the Surgical Division of Bausch & Lomb. Mr. Owens earned a bachelor's degree and a master's degree in Plastics Engineering from the University of Massachusetts, Lowell, and an MBA from the University of Phoenix.

The Company also appointed veteran medical device executive William W. Burke to Executive Vice President and Chief Financial Officer. Mr. Burke has more than 25 years of medical technology experience as a board member, senior executive and acquisition and financing advisor. He currently serves on the board of directors of Medical Action Industries, Inc. and Aperio Technologies, Inc. From 2004 through 2007, he was Executive Vice President and Chief Financial Officer of ReAble Therapeutics, Inc. From 2001 to 2004, he served as Chief Financial Officer of Cholestech Corporation. Most recently, he served as President of Emergent Technologies, Inc. He earned a BBA in finance from the University of Texas at Austin and an MBA from The Wharton Graduate Business School at the University of Pennsylvania.

"Bill's extensive experience and capabilities as a CFO and healthcare executive will enable IDEV to accelerate our growth strategy," Mr. Anderson said. "We believe that Chris and Bill provide IDEV with an impressive combination of senior executive leadership, skills and experience. Under the leadership of these talented individuals, we look forward to a prosperous future."

"I believe we are building a strong foundation for growth and expansion for the treatment of biliary and peripheral artery disease," Mr. Owens said. "We have a robust technology portfolio and we will be expanding and leveraging our technologies into other markets, where it makes sense to do so."

In anticipation of future growth, IDEV has recently moved into an expanded, world-class facility in Webster, TX, Mr. Owens added.

About IDEV Technologies, Incorporated

IDEV Technologies, Incorporated (IDEV) is an innovator and developer of next generation medical devices for use in the interventional radiology, vascular surgery and cardiology device marketplace. IDEV worldwide headquarters is located in Webster, Texas with the European headquarters in Beuningen, Netherlands.

    Contact:  Julie Nguyen, Marketing Communications Manager
              IDEV Technologies, Incorporated
              (281) 525-2000

SOURCE IDEV Technologies, Incorporated


'/>"/>
SOURCE IDEV Technologies, Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
2. King Pharmaceuticals and Palatin Technologies Delay Immediate Plans for Phase 3 Clinical Program With Bremelanotide for Erectile Dysfunction
3. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
4. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
5. New Clinical Studies Confirm Mauna Kea Technologies Cellvizio(R) GI in Range of Procedures
6. Palatin Technologies, Inc. Reports Initiation of Human Trials for the Treatment of Congestive Heart Failure
7. Emisphere Technologies, Inc. Announces 2007 Third Quarter Financial Results
8. Senesco Technologies Initiates Preclinical Studies for Cancer Target
9. ASEAN News: Epeius Biotechnologies Gains Commercial Approval for Rexin-G(R), a Tumor-Targeted Gene-Based Medicine for Metastatic Cancer
10. Epeius Biotechnologies Applauds the Belated Scholarship of Their Academic Contemporaries in 2007, As Targeted Gene Therapy Comes of Age in Clinical Medicine
11. TCS Healthcare Technologies Releases Three New Clinical Care Programs Within ACUITY
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 Research ... Devices Global Market - Forecast to 2022" report to ... the treatment method for the patients with kidney failure, it ... excess fluid from the patient,s blood and thus the treatment ... potassium and chloride in balance. Increasing number ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: ... 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) assay ... sepsis or septic shock. With this clearance, Roche is ... a fully integrated solution for sepsis risk assessment and ... with bacterial infection and PCT levels in blood can ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... , ... The temporary closing of Bruton Memorial Library on June 21 due to a possible ... often overlooked aspect of head lice: the parasite’s ability to live away from a human ... but a necessary one in the event that lice have simply gotten out of control. ...
(Date:6/25/2016)... , ... June 25, 2016 , ... First Choice ... States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm ... Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... Those ... deal with these feelings, many turn to unhealthy avenues, such as drug or alcohol ... of Marne, Michigan, has released tools for healthy coping following a traumatic event. , ...
Breaking Medicine News(10 mins):